Blackwell Kimberly
SEC insider (Form 3/4/5 filer). CIK 0001816465. Director at Century Therapeutics, Inc. (IPSC) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in BOSTON, MA.
Companies Blackwell Kimberly has filed insider reports for
- Century Therapeutics, Inc. (IPSC): Director
- Monte Rosa Therapeutics, Inc. (GLUE): Director
Blackwell Kimberly
CIK: 0001816465
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 11, 2026IPSC
Century Therapeutics, Inc.
AwardDirectStock Option (right to buy)
74K shares- - Jun 11, 2026GLUE
Monte Rosa Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
25.8K shares- - Jun 13, 2025GLUE
Monte Rosa Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
30.7K shares- - Jun 12, 2025IPSC
Century Therapeutics, Inc.
AwardDirectStock Option (right to buy)
44K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  IPSC Century Therapeutics, Inc. | Award Stock Option (right to buy) | 74,000 | - | - | Direct |
| Jun 11, 2026 |  GLUE Monte Rosa Therapeutics, Inc. | Award Stock Option (Right to Buy) | 25,800 | - | - | Direct |
| Jun 13, 2025 | GLUE Monte Rosa Therapeutics, Inc. | Award Stock Option (Right to Buy) | 30,700 | - | - | Direct |
| Jun 12, 2025 | IPSC Century Therapeutics, Inc. | Award Stock Option (right to buy) | 44,000 | - | - | Direct |
1-4 of 4 transactions